Fuji Pharma Co., Ltd. (4554.T)
JPY 1355.0
(-0.51%)
JPY 1355.0
(-0.51%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 19.37 Billion JPY | 22.42% |
| 2022 | 15.82 Billion JPY | 31.79% |
| 2021 | 12 Billion JPY | 12.42% |
| 2020 | 10.68 Billion JPY | -0.29% |
| 2019 | 10.71 Billion JPY | -5.08% |
| 2018 | 11.28 Billion JPY | -1.75% |
| 2017 | 11.48 Billion JPY | -0.72% |
| 2016 | 11.56 Billion JPY | 1.52% |
| 2015 | 11.39 Billion JPY | 24.52% |
| 2014 | 9.15 Billion JPY | 40.01% |
| 2013 | 6.53 Billion JPY | -1.13% |
| 2012 | 6.61 Billion JPY | 25.79% |
| 2011 | 5.25 Billion JPY | 7.79% |
| 2010 | 4.87 Billion JPY | 24.1% |
| 2009 | 3.92 Billion JPY | 19.76% |
| 2008 | 3.28 Billion JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 20.85 Billion JPY | 1.48% |
| 2024 Q1 | 20.54 Billion JPY | 6.07% |
| 2024 Q3 | 20.15 Billion JPY | -3.34% |
| 2023 Q2 | 17.77 Billion JPY | 11.3% |
| 2023 Q4 | 19.37 Billion JPY | 4.57% |
| 2023 FY | 19.37 Billion JPY | 22.42% |
| 2023 Q1 | 15.96 Billion JPY | 0.92% |
| 2023 Q3 | 18.52 Billion JPY | 4.23% |
| 2022 Q3 | 14.82 Billion JPY | 10.68% |
| 2022 Q1 | 12.33 Billion JPY | 2.72% |
| 2022 Q2 | 13.39 Billion JPY | 8.59% |
| 2022 FY | 15.82 Billion JPY | 31.79% |
| 2022 Q4 | 15.82 Billion JPY | 6.75% |
| 2021 Q3 | 11.14 Billion JPY | 3.42% |
| 2021 Q1 | 10.84 Billion JPY | 1.54% |
| 2021 FY | 12 Billion JPY | 12.42% |
| 2021 Q4 | 12 Billion JPY | 7.7% |
| 2021 Q2 | 10.77 Billion JPY | -0.6% |
| 2020 FY | 10.68 Billion JPY | -0.29% |
| 2020 Q2 | 11.89 Billion JPY | 7.6% |
| 2020 Q3 | 11.81 Billion JPY | -0.64% |
| 2020 Q1 | 11.05 Billion JPY | 3.18% |
| 2020 Q4 | 10.68 Billion JPY | -9.61% |
| 2019 Q2 | 11.17 Billion JPY | -2.11% |
| 2019 Q3 | 11.2 Billion JPY | 0.24% |
| 2019 Q4 | 10.71 Billion JPY | -4.37% |
| 2019 FY | 10.71 Billion JPY | -5.08% |
| 2019 Q1 | 11.41 Billion JPY | 1.16% |
| 2018 FY | 11.28 Billion JPY | -1.75% |
| 2018 Q4 | 11.28 Billion JPY | -4.37% |
| 2018 Q3 | 11.8 Billion JPY | 1.79% |
| 2018 Q2 | 11.59 Billion JPY | -0.97% |
| 2018 Q1 | 11.7 Billion JPY | 1.92% |
| 2017 Q2 | 11.69 Billion JPY | -5.78% |
| 2017 Q1 | 12.41 Billion JPY | 7.34% |
| 2017 FY | 11.48 Billion JPY | -0.72% |
| 2017 Q4 | 11.48 Billion JPY | -5.81% |
| 2017 Q3 | 12.19 Billion JPY | 4.22% |
| 2016 Q1 | 12 Billion JPY | 5.34% |
| 2016 FY | 11.56 Billion JPY | 1.52% |
| 2016 Q3 | 12.46 Billion JPY | 3.62% |
| 2016 Q4 | 11.56 Billion JPY | -7.23% |
| 2016 Q2 | 12.03 Billion JPY | 0.24% |
| 2015 Q3 | 11.85 Billion JPY | 2.27% |
| 2015 Q2 | 11.59 Billion JPY | 11.03% |
| 2015 Q1 | 10.44 Billion JPY | 14.11% |
| 2015 FY | 11.39 Billion JPY | 24.52% |
| 2015 Q4 | 11.39 Billion JPY | -3.9% |
| 2014 Q2 | 7.93 Billion JPY | -0.11% |
| 2014 Q1 | 7.94 Billion JPY | 21.48% |
| 2014 FY | 9.15 Billion JPY | 40.01% |
| 2014 Q3 | 9.3 Billion JPY | 17.36% |
| 2014 Q4 | 9.15 Billion JPY | -1.69% |
| 2013 FY | 6.53 Billion JPY | -1.13% |
| 2013 Q1 | 7.39 Billion JPY | 11.79% |
| 2013 Q4 | 6.53 Billion JPY | -5.32% |
| 2013 Q2 | 7.49 Billion JPY | 1.39% |
| 2013 Q3 | 6.9 Billion JPY | -7.87% |
| 2012 FY | 6.61 Billion JPY | 25.79% |
| 2012 Q4 | 6.61 Billion JPY | -0.12% |
| 2012 Q3 | 6.61 Billion JPY | 5.09% |
| 2012 Q2 | 6.29 Billion JPY | 7.35% |
| 2012 Q1 | 5.86 Billion JPY | 11.64% |
| 2011 FY | 5.25 Billion JPY | 7.79% |
| 2011 Q3 | 5.26 Billion JPY | 6.83% |
| 2011 Q1 | 4.8 Billion JPY | -1.44% |
| 2011 Q4 | 5.25 Billion JPY | -0.15% |
| 2011 Q2 | 4.92 Billion JPY | 2.52% |
| 2010 Q3 | 4.37 Billion JPY | -6.25% |
| 2010 Q1 | 3.94 Billion JPY | 0.52% |
| 2010 Q2 | 4.66 Billion JPY | 18.12% |
| 2010 FY | 4.87 Billion JPY | 24.1% |
| 2010 Q4 | 4.87 Billion JPY | 11.48% |
| 2009 Q2 | 3.66 Billion JPY | 1.98% |
| 2009 Q1 | 3.59 Billion JPY | 0.0% |
| 2009 Q4 | 3.92 Billion JPY | 0.0% |
| 2009 FY | 3.92 Billion JPY | 19.76% |
| 2008 FY | 3.28 Billion JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 6.71 Billion JPY | -188.388% |
| Takeda Pharmaceutical Company Limited | 1209.86 Billion JPY | 98.399% |
| Sumitomo Pharma Co., Ltd. | 115.35 Billion JPY | 83.207% |
| Shionogi & Co., Ltd. | 64.91 Billion JPY | 70.16% |
| Wakamoto Pharmaceutical Co.,Ltd. | 2 Billion JPY | -865.636% |
| Nippon Shinyaku Co., Ltd. | 39.11 Billion JPY | 50.472% |
| Kaken Pharmaceutical Co., Ltd. | 17.16 Billion JPY | -12.839% |
| Eisai Co., Ltd. | 174.65 Billion JPY | 88.909% |
| Morishita Jintan Co., Ltd. | 3.18 Billion JPY | -508.195% |
| Hisamitsu Pharmaceutical Co., Inc. | 21.17 Billion JPY | 8.524% |
| Mochida Pharmaceutical Co., Ltd. | 30.27 Billion JPY | 36.023% |
| Fuso Pharmaceutical Industries,Ltd. | 14.2 Billion JPY | -36.396% |
| Nippon Chemiphar Co., Ltd. | 10.72 Billion JPY | -80.666% |
| Tsumura & Co. | 117.61 Billion JPY | 83.53% |
| Kissei Pharmaceutical Co., Ltd. | 26.29 Billion JPY | 26.335% |
| Torii Pharmaceutical Co., Ltd. | 10.74 Billion JPY | -80.33% |
| Towa Pharmaceutical Co., Ltd. | 101.07 Billion JPY | 80.834% |
| Zeria Pharmaceutical Co., Ltd. | 14.48 Billion JPY | -33.688% |
| KYORIN Holdings, Inc. | 53.47 Billion JPY | 63.772% |
| Taiko Pharmaceutical Co.,Ltd. | 1.95 Billion JPY | -892.367% |
| Daito Pharmaceutical Co.,Ltd. | 20.89 Billion JPY | 7.271% |
| SymBio Pharmaceuticals Limited | 232.03 Million JPY | -8248.489% |
| MedRx Co., Ltd | 10 Million JPY | -193610.0% |
| Mizuho Medy Co.,Ltd. | 1.59 Billion JPY | -1113.26% |
| Solasia Pharma K.K. | 122 Million JPY | -15777.869% |
| Modalis Therapeutics Corporation | 6.35 Million JPY | -304811.066% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 20.4 Billion JPY | 5.053% |
| Sawai Group Holdings Co., Ltd. | 100 Billion JPY | 80.629% |
| Cyfuse Biomedical K.K. | 46.04 Million JPY | -41969.714% |
| Toho Holdings Co., Ltd. | 87.28 Billion JPY | 77.808% |
| Koa Shoji Holdings Co.,Ltd. | 2.26 Billion JPY | -754.757% |